Vilnius Declaration: European Governments Need To Take Immediate Action

Austerity cuts have put Europe’s health systems under severe pressure, increasing health inequalities and threatening sustainability in the future. Now, European governments and the European Union (EU) need to take immediate action to prevent further damage.

Vilnius Declaration: European Governments Need To Take Immediate Action2018-03-06T15:35:11+02:00

Harnessing big data to improve R&D and the translation of new therapies

With health care under pressure from many angles, the key issue is to ensure sustainability of health systems in the face of these challenges. Rational application of big data has an important role to play.

Harnessing big data to improve R&D and the translation of new therapies2018-03-07T08:39:57+02:00

Sustainable Health Systems for Inclusive Growth in Europe

Sustainable Health Systems for Inclusive Growth in Europe   Conference Report Austerity cuts have put Europe’s health systems under severe pressure, increasing health inequalities and threatening sustainability in the future. Now, European governments and the European Union (EU) need to take immediate action to prevent further damage. The inspiration for the Vilnius Declaration, agreed at [...]

Sustainable Health Systems for Inclusive Growth in Europe2018-03-06T15:38:51+02:00

ABPI toolkit will help members manage clinical trials disclosure process

Research by the ABPI indicates current statistics on the state of play in transparency are not accurate. A toolkit will guide members in complying with disclosure requirements and generate more reliable information on compliance.

ABPI toolkit will help members manage clinical trials disclosure process2018-03-07T08:43:44+02:00

European pharma industry stages workshop to consider practical issues involved in clinical trials data transparency

After setting out principles under which the industry is prepared to open up clinical study reports, the European Federation of Pharmaceutical Industries and Associations (EFPIA) is trying to reach a consensus with campaigners and regulators on how they should be applied in practice.

European pharma industry stages workshop to consider practical issues involved in clinical trials data transparency2018-03-07T08:46:35+02:00
Go to Top